ABA	abatacept
ADA	adalimumab
ANA	anakinra
BAR	baricitinib
bDMARD	biological DMARD
CAN	canakinumab
CER	certolizumab
csDMARD	conventional synthetic DMARD
DMARD	disease modifying anti-rheumatic drug
ERA	enthesitis related arthritis
ETA	etanercept
GOL	golimumab
HCQ	hydroxychloroquin
IFN	interferone
IL	interleukine
IXE	ixekizumab
JAK	janus kinase
JIA	juvenile idiopathic arthritis
JPsA	juvenile psoriatic arthritis
MAS/sHLH	macrophage activation syndrome/secondary haemophagocytic lymphohistiocytosis
MTX	methotrexate
n/a	not available
SAR	sarilumab
SEC	secukinumab
sJIA	systemic JIA
SUL	sulfasalazine
TNF	tumor necrosis factor
TOC	tocilizumab
TOF	tofacitinib
tsDMARD	targeted synthetic DMARD
UPA	upadacitinib